Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia.
Masternak M, Puła B, Knap J, Waszczuk-Gajda A, Drozd-Sokołowska J, Wdowiak K, Grosicki S, Kozłowska I, Kaźmierczak M, Łabędź A, Szukalski Ł, Wiśniewski K, Subocz E, Hałka J, Szymczyk A, Hus M, Jamroziak K, Giannopoulos K. Masternak M, et al. Among authors: pula b. Cancer Manag Res. 2020 Oct 12;12:9977-9985. doi: 10.2147/CMAR.S246385. eCollection 2020. Cancer Manag Res. 2020. PMID: 33116854 Free PMC article.
Current Treatment of Chronic Lymphocytic Leukemia.
Jamroziak K, Puła B, Walewski J. Jamroziak K, et al. Among authors: pula b. Curr Treat Options Oncol. 2017 Jan;18(1):5. doi: 10.1007/s11864-017-0448-2. Curr Treat Options Oncol. 2017. PMID: 28185174 Review.
Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG).
Puła B, Budziszewska BK, Rybka J, Gil L, Subocz E, Długosz-Danecka M, Zawirska D, Waszczuk-Gajda A, Iskierka-Jażdżewska E, Kopacz A, Szymczyk A, Czyż J, Lech-Marańda E, Warzocha K, Jamroziak K. Puła B, et al. Anticancer Res. 2018 May;38(5):3025-3030. doi: 10.21873/anticanres.12557. Anticancer Res. 2018. PMID: 29715135
Immunochemotherapy for Richter syndrome: current insights.
Puła B, Salomon-Perzyński A, Prochorec-Sobieszek M, Jamroziak K. Puła B, et al. Immunotargets Ther. 2019 Feb 5;8:1-14. doi: 10.2147/ITT.S167456. eCollection 2019. Immunotargets Ther. 2019. PMID: 30788335 Free PMC article. Review.
Pixantrone, etoposide, bendamustine, rituximab (P[R]EBEN) as an effective salvage regimen for relapsed/refractory aggressive non-Hodgkin lymphoma-Polish Lymphoma Research Group real-life analysis.
Długosz-Danecka M, Hus I, Puła B, Jurczyszyn A, Chojnacki T, Blajer-Olszewska B, Drozd-Sokołowska J, Raźny M, Romejko-Jarosińska J, Taszner M, Jurczak W. Długosz-Danecka M, et al. Among authors: pula b. Pharmacol Rep. 2019 Jun;71(3):473-477. doi: 10.1016/j.pharep.2019.02.001. Epub 2019 Feb 6. Pharmacol Rep. 2019. PMID: 31003160
Ibrutinib discontinuation in patients with relapsed or refractory chronic lymphocytic leukemia treated in a compassionate use program: A report from the Polish Adult Leukemia Study Group (PALG).
Iskierka-Jażdżewska E, Puła B, Szeremet A, Hus M, Gołos A, Hołojda J, Piszczek W, Steckiewicz P, Wojciechowska M, Zaucha JM, Warzocha K, Jamroziak K. Iskierka-Jażdżewska E, et al. Among authors: pula b. Adv Clin Exp Med. 2019 Aug;28(8):1051-1057. doi: 10.17219/acem/99911. Adv Clin Exp Med. 2019. PMID: 31199879 Free article.
Autologous stem cell transplantation in the treatment of multiple myeloma with 17p deletion.
Czyż J, Jurczyszyn A, Szudy-Szczyrek A, Koclęga A, Jachalska A, Dzierżak-Mietła M, Puła B, Jamroziak K, Usnarska-Zubkiewicz L, Gil L, Romejko-Jarosińska J, Waszczuk-Gajda A. Czyż J, et al. Among authors: pula b. Pol Arch Intern Med. 2020 Feb 27;130(2):106-111. doi: 10.20452/pamw.15139. Epub 2020 Jan 14. Pol Arch Intern Med. 2020. PMID: 31933484 Free article.
The impact of cytogenetic evolution and acquisition of del(17p) on the prognosis of patients with multiple myeloma.
Salomon-Perzyński A, Bluszcz A, Krzywdzińska A, Spyra-Górny Z, Jakacka N, Barankiewicz J, Borg K, Solarska I, Szpila T, Puła B, Grosicki S, Jamroziak K. Salomon-Perzyński A, et al. Among authors: pula b. Pol Arch Intern Med. 2020 Jun 25;130(6):483-491. doi: 10.20452/pamw.15316. Epub 2020 Apr 27. Pol Arch Intern Med. 2020. PMID: 32338840 Free article.
Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study.
Pula B, Iskierka-Jazdzewska E, Dlugosz-Danecka M, Szymczyk A, Hus M, Szeremet A, Drozd-Sokolowska J, Waszczuk-Gajda A, Zaucha JM, Holojda J, Piszczek W, Steckiewicz P, Wojciechowska M, Osowiecki M, Knopinska-Posluszny W, Dudzinski M, Zawirska D, Subocz E, Halka J, Pluta A, Wichary R, Kumiega B, Budziszewska BK, Jurczak W, Lech-Maranda E, Giannopoulos K, Robak T, Jamroziak K. Pula B, et al. Anticancer Res. 2020 Jul;40(7):4059-4066. doi: 10.21873/anticanres.14403. Anticancer Res. 2020. PMID: 32620653
114 results